MD
Insider
Mardi Dier
SVP and CFOMardi Dier (SVP and CFO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $2.1M of MDGL (3,579 sh across 10 lots, as filed), executed Dec 2 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.0M
shares × price, as filed
Last traded
Mar 6
Filed Mar 6
Median ADV $194.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
MDGLRecent filings
MDGLSALE
Madrigal Pharmaceuticals, Inc.
View filing →
$458K1,066 sh across 2 lots
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $505K
1,183 sh × $427.21
Exec Mar 2
Filed Mar 2 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $2.1M
3,579 sh across 10 lots
Exec Dec 2 2025
Filed Dec 3 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $637K
1,961 sh across 2 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET